GW Pharmaceuticals Plc (GWPH)

122.75
2.71 2.16
NASDAQ : Health Technology
Prev Close 125.46
Open 123.51
Day Low/High 121.25 / 124.27
52 Wk Low/High 67.98 / 182.05
Volume 363.30K
Avg Volume 512.00K
Exchange NASDAQ
Shares Outstanding 31.08M
Market Cap 3.90B
EPS -0.30
P/E Ratio 1,254.60
Div & Yield N.A. (N.A)

Latest News

Jim Cramer: The HQ for Innovation Is Right Here in San Francisco

Jim Cramer: The HQ for Innovation Is Right Here in San Francisco

The NYSE used to be the center of capitalism, but now it's where actual engineering, not financial engineering, is taking place.

The Market Is Still in Reset Mode, but Indices Are Holding Up

The Market Is Still in Reset Mode, but Indices Are Holding Up

Many stocks need rest and small-cap earnings season is rocky, but that doesn't mean the indices are going to see significant downside.

Jim Cramer: Let's Wait for Full Story on Promising GW Pharma Drug

Jim Cramer: Let's Wait for Full Story on Promising GW Pharma Drug

After a negative report on GW's epilepsy treatment, the analyst refused to explain the results with me, bringing more questions than answers about its conclusions.

GW Pharmaceuticals Could Fall Another 30% From Here

GW Pharmaceuticals Could Fall Another 30% From Here

Shares of the cannabinoid prescription medicine company look to be in a weak state.

CBD-Laced Foods Could Be Technically Illegal, But the FDA Might Soon Change That

CBD-Laced Foods Could Be Technically Illegal, But the FDA Might Soon Change That

Agency has the authority to carve out an exception to existing laws.

The Rally in GW Pharmaceuticals Should Continue - Here's How I'd Play It

The Rally in GW Pharmaceuticals Should Continue - Here's How I'd Play It

Let's see how the charts of GWPH are shaping up.

Zynerba Pharma Looks Like Bad Medicine for Investors

Zynerba Pharma Looks Like Bad Medicine for Investors

The charts make ZYNE look bearish and not particularly attractive, so avoid.

5 Cannabis ETFs to Fire Up Your Portfolio

5 Cannabis ETFs to Fire Up Your Portfolio

Two of them are brand new.

You Don't Have to Swing for the Fences With Every Investment in Small Caps

You Don't Have to Swing for the Fences With Every Investment in Small Caps

The way I do that is by using buy-write option strategies.

9 Speculative Plays for Investors Wanting Cannabis Exposure

9 Speculative Plays for Investors Wanting Cannabis Exposure

Five top marijuana stocks and four CBD plays in this speculative space.

2 Hemp Stocks for Investors Looking for Something Different

2 Hemp Stocks for Investors Looking for Something Different

You may want to check out GW Pharmaceuticals and Elixinol Global Limited.

Melius Research Launches Cannabis Industry Coverage

Melius Research Launches Cannabis Industry Coverage

In its first report on cannabis companies, Melius says prices are high.

GW Pharmaceuticals Is Ready to Rally More: How to Trade This Cannabis Stock

GW Pharmaceuticals Is Ready to Rally More: How to Trade This Cannabis Stock

My trading strategy for GWPH whether you are currently long or want to be.

Jim Cramer: My Best Stock Picks for Cannabis and China

Jim Cramer: My Best Stock Picks for Cannabis and China

And why I won't recommend any other stocks in these markets, right now.

Why Canada Rules as a Haven for Listing Cannabis Companies

Why Canada Rules as a Haven for Listing Cannabis Companies

The main reason most cannabis-related concerns head north to list their shares is banking.

Farm Bill's Hemp Legalization Is Poised to Boost These 2 Stocks

Farm Bill's Hemp Legalization Is Poised to Boost These 2 Stocks

Despite the current stock market, investors are still looking for ways to play the new legalization of hemp.

GW Pharmaceuticals Is Poised to Rally to New Highs, Risk Defined

GW Pharmaceuticals Is Poised to Rally to New Highs, Risk Defined

A potential great pipeline but let's check the charts.

Check Out These Stocks as Canada Is About to Be Smokin' Hot

Check Out These Stocks as Canada Is About to Be Smokin' Hot

On Wednesday, Canada becomes the first major economy to legalize the recreational use of cannabis.

Canopy Growth and 4 Other Cannabis Stocks That Look Good Here

Canopy Growth and 4 Other Cannabis Stocks That Look Good Here

These stocks offer some diversification or unique features in the legal-weed space.

Down the Marijuana Rabbit Hole: 5 Companies to Consider

It's too easy to lump all cannabis-related stocks into the moniker "marijuana." Like many other sectors, there are differentiators underneath the same way we see in semiconductors or retail or even energy.  As you go down the marijuana rabbit hole, ...

Legalized Recreational Marijuana Won't Kill Medical Marijuana

Legalized Recreational Marijuana Won't Kill Medical Marijuana

Sales trends and the potential for stronger versions of prescription cannabis offer medical marijuana providers hope.

Insys Therapeutics Is a Pretend Cannabis Stock

Insys Therapeutics Is a Pretend Cannabis Stock

It is time for investors to start differentiating between the Good, the Bad and the Ugly in cannabis stocks.

FDA Approval Puts GW Pharma, Three Other Cannabis-Related Names in the Spotlight

FDA Approval Puts GW Pharma, Three Other Cannabis-Related Names in the Spotlight

The milestone approval of Epidiolex bodes well for cannabis-based drug stocks GW Pharma, Nemus, Zynerba and Insys.

Seven U.S. Stocks Offering Cannabis Exposure

Seven U.S. Stocks Offering Cannabis Exposure

While cannabis remains illegal on a federal level, these seven names are making early inroads into the growing industry.

Jim Cramer: These 4 Cold Stocks of Once-Hot Companies Could Reignite

Jim Cramer: These 4 Cold Stocks of Once-Hot Companies Could Reignite

It's important to know the difference between broken stocks and broken companies.

The Market Is Finally Rewarding Stock Picking

The Market Is Finally Rewarding Stock Picking

The game plan is to spot the charts that have more room to run.

Here Is the Buzz on My Under-the-Radar Top ETF Pick for 2018

Here Is the Buzz on My Under-the-Radar Top ETF Pick for 2018

Look for this name to jump quickly in popularity in 2018 as investors players search for a convenient way to play the marijuana niche.

President Trump Looks Set for a Major Victory on Tax Reform: Market Recon

President Trump Looks Set for a Major Victory on Tax Reform: Market Recon

Party leaders will have to work toward merging the two versions of tax reform into one final bill.